Behind the surge in AVAV's stock price: How does AeroVironment benefit from the global expansion of defense spending?

On June 29, 2026, AeroVironment (Nasdaq code: AVAV) released its Q4 and full-year fiscal 2026 earnings report. Its stock price surged rapidly in after-hours trading, with a maximum gain of more than 20%. The next trading day, the intraday gain expanded further to 23%. As of the close on June 30, AVAV was at $165.07, with a daily gain of 18.76%.

This defense technology company headquartered in Virginia mainly operates across unmanned aerial vehicle (UAV) systems, loitering munitions, counter-UAV technology, space and cyber warfare capabilities, and directed energy weapons. Its core products include the Switchblade series of loitering munitions, the Puma and Raven reconnaissance drones, and the LOCUST laser weapon system.

The market paid unusually close attention to this earnings release from AVAV not only because the figures themselves were compelling, but also because it touches on a series of core questions facing the current global defense technology industry: How are geopolitical conflicts reshaping military procurement logic? Where will the structural expansion of defense budgets flow in terms of technology direction? For a defense contractor deeply embedded in the U.S. military supply chain, where is its growth ceiling?

How Strong Were the Performance Data, Really?

In Q4 of fiscal 2026, AeroVironment achieved revenue of $641.6 million, up 133% year over year, significantly exceeding the analyst consensus estimate of approximately $558 million. Full-year revenue reached $1.977 billion, up 141% year over year.

Profitability also beat market expectations. In the fourth quarter, non-GAAP adjusted earnings per share were $1.84, about 25% higher than the analysts’ expected $1.47. On a GAAP basis, quarterly net profit was $63.2 million, up nearly 280% year over year.

Growth momentum came from multiple fronts. First, the BlueHalo acquisition completed in May 2025 and the ESAero acquisition completed in March 2026 together contributed more than $282 million in revenue for the quarter. Even after excluding the contribution from acquisitions, organic growth was still 31%. Second, the Autonomous Systems (AxS) segment recorded revenue of $492.4 million, accounting for 76% of the company’s total revenue. Within that, the Precision Strike and Defense business (including the Switchblade, Red Dragon, and Titan product lines) reached $333 million, up 80% year over year.

Looking at the year-over-year comparison base, Q4 of fiscal 2025 revenue was $275 million, which means that over the past year AVAV expanded its revenue scale to more than double.

How to Understand the Contradiction Between Order Backlog and Earnings Guidance

In the earnings report, there is one piece of data that is more worth attention than the current-period revenue—orders. Full-year fiscal 2026 bookings reached $2.7 billion, and the book-to-bill ratio was 1.4, indicating that the growth rate of new orders is clearly faster than the pace of revenue recognition. As of the end of the reporting period, funded backlog—backlog with funding allocated—reached $1.2 billion, up 65% year over year.

The rapid growth in orders reflects strong demand at the end market. Orders for the company’s counter-UAV systems and laser weapons doubled. In June 2026, the U.S. Army awarded AeroVironment a $117 million contract to purchase 82 P550 unmanned aircraft systems. That same month, the company also received a $20 million contract from the U.S. Air Force Research Laboratory for aerospace ceramic materials. In May, the U.S. Army selected the Switchblade 400 as a key component of the LASSO program.

However, the company’s guidance for fiscal 2027 was below market expectations. Management expects fiscal 2027 revenue to range from $2.13 billion to $2.23 billion, and non-GAAP adjusted earnings per share to range from $3.02 to $3.34. Among these, the earnings guidance was notably below the market’s earlier expectations of $3.85 to $4.00.

The reason the guidance is on the low side is a major increase in capital expenditures. The company plans to raise capital expenditures as a percentage of revenue from 5% in fiscal 2026 to 12% to 14% in fiscal 2027, to expand production capacity for Switchblade missiles and laser weapons. This is expected to increase depreciation and amortization expenses by approximately $37 million. In addition, the cancellation of the SCAR contract and the natural decline in Ukraine-related revenue each constitute roughly 5% headwinds.

The market reaction is noteworthy—investors clearly prioritize order momentum over short-term profit guidance. The $1.2 billion funded backlog provides revenue visibility for the next 12 to 18 months, while the planned ramp-up in capital expenditures is viewed as the necessary upfront investment to meet structural demand.

How Will the Structural Expansion of Global Defense Spending Affect AVAV?

AVAV’s earnings surge is not an isolated event; it is embedded in a larger macro narrative. Global defense spending is in the most significant expansion cycle since the end of the Cold War.

According to Forecast International, global defense spending will exceed $2.6 trillion in 2026, up 8.1% from 2025. Even the U.S. defense budget alone has already reached roughly $1 trillion in fiscal 2026, a historic high. The drivers behind this military spending expansion include the continued Russia-Ukraine war, accelerating U.S.-China strategic competition, and the spread of regional instability factors.

Within this military spending expansion, the flow of funds shows clear structural characteristics. The growth rate for procurement of traditional manned platforms (tanks, fighter jets, warships) is slowing, while unmanned systems, precision-guided munitions, counter-UAV technology, and space capabilities are taking up increasingly larger shares of the budget.

The military drone market is expected to grow from $34.85 billion in 2026 to $109.22 billion in 2031, with a CAGR of 25.7%. Counter-UAV systems spending is expected to reach $12.6 billion in 2026 and to increase to $24.1 billion by 2030. The directed energy weapons market is expected to grow from approximately $4.58 billion in 2026 to $12.11 billion in 2035.

AeroVironment’s product portfolio happens to cover these three fastest-growing segments. During the earnings call, CEO Wahid Nawabi said that recent global geopolitical conflicts have fundamentally reshaped the nature of warfare, and that demand for drones, counter-UAV technology, and space technology is now entering a structural inflection point. He pointed out that, by itself, the U.S. Department of Defense’s annual drone budget could exceed $75 billion next year.

Controversies and Risks: Shadows in the High-Growth Narrative

Every high-growth story has another side. From the beginning of 2026 to now, AVAV’s stock price is down more than 42%, even though it rebounded sharply after the earnings release. This decline reflects the market pricing multiple risks.

First, there are financial restatements and internal control issues. The company previously restated its financials due to the cancellation of the SCAR contract and disclosed that there were material weaknesses in internal controls. A securities fraud class action lawsuit has been filed against the company regarding its statements about the SCAR contract.

Second is customer concentration risk. AVAV’s revenue is highly dependent on procurement decisions made by the U.S. Department of Defense and its allies. Any budget cuts, project cancellations, or adjustments to procurement priorities could have a significant impact on the company’s performance. The cancellation of the SCAR contract has already demonstrated the reality of this risk.

Third is the execution risk of capacity expansion. The company plans to significantly increase capital expenditures over the next year. This is both a prerequisite for growth and a source of short-term pressure on profits. Uncertainty remains around the speed of capacity expansion, cost control, and the utilization rate of new capacity.

Fourth is valuation divergence. Although the stock price has fallen substantially from its peak, different institutions have vastly different valuation judgments on AVAV. Wedbush set a target price of $250, Stifel lowered its target price to $220, and the institutional consensus target-price median compiled by Barchart is about $295. The target-price range spans from $172 to $400.

What Institutions Think: Divergence Within the Consensus

Despite the risks mentioned above, Wall Street’s overall rating on AVAV still leans optimistic. Zacks rates AVAV as Level 3 (Hold), while the institutional consensus rating compiled by Barchart is “Strong Buy.”

After the earnings release, Wedbush gave AVAV an “Outperform” rating with a $250 target price, believing that the company’s cross-domain capabilities across air, land, sea, space, and cyber provide a lasting competitive advantage. Wedbush’s analysts acknowledged the recent pressures the company faces from financial restatements and contract cancellations, but they believe these factors instead create more attractive valuations for investors looking to position for next-generation defense technology. The firm specifically emphasized that AVAV’s battle-proven products “form a durable moat that new entrants cannot replicate within a relevant time window.”

Stifel maintained a Buy rating but lowered its target price from $315 to $220. The primary reason for the downgrade was that higher capital expenditures dilute short-term profits. Stifel’s valuation benchmark is 30 times fiscal 2028 EBITDA.

Notably, despite generally positive institutional ratings, AVAV’s stock has fallen 51% over the past year and is currently trading near its 52-week low of $135.20. This suggests that the market has already digested a large amount of negative information, and the earnings performance above expectations may be a signal of a fundamental turnaround.

An Investment Analysis Framework for Defense-Tech Assets Through the AVAV Case

The AVAV case provides an analytical framework for understanding defense-tech assets.

The first dimension is order visibility. Unlike traditional commercial companies, defense contractors’ revenue depends heavily on government contract schedules and funding timing. Therefore, backlog—especially funded backlog—reflects true demand better than current-period revenue. AVAV’s $1.2 billion in funded backlog provides revenue visibility for at least the next 12 months, which is an important support for its valuation.

The second dimension is the match between the product portfolio and the structure of defense budgets. AVAV’s drones, loitering munitions, counter-UAV systems, and laser weapons cover precisely several sub-sectors within defense budgets that are growing the fastest. This kind of structural alignment determines whether the company can continue to benefit from military spending expansion over the medium to long term.

The third dimension is the relationship between M&A integration and organic growth. AVAV achieved a jump in revenue through the acquisitions of BlueHalo and ESAero, but M&A also brings risks such as integration challenges, goodwill impairment, and financial restatements. Investors need to distinguish which portions of growth are sustainable organic growth and which portions are one-off M&A contributions.

The fourth dimension is the mismatch between the capital expenditure cycle and the profit cycle. Defense-tech companies often need to invest heavily in capacity early when demand surges. This suppresses profit margins in the short term but lays the foundation for growth in the medium to long term. AVAV is currently in this phase, and the market’s response to its profit guidance will depend on how much of a premium investors are willing to pay for long-term growth.

Summary

AeroVironment’s fiscal 2026 earnings report presents a typical picture of a defense technology company during a structural demand expansion cycle: rapid growth in both revenue and orders, capacity expansion weighing on short-term profits, and valuation oscillating between optimism and caution. Its core investment logic is built on the long-term trend of global defense spending shifting toward unmanned systems and directed energy weapons, while short-term risks come from customer concentration, uncertainty in contract execution, and the profit-dilutive effect of capacity investments. AVAV’s subsequent performance will depend on whether the company can convert its $1.2 billion backlog into sustainable revenue growth and find a balance between capacity expansion and profit margins.

Frequently Asked Questions (FAQ)

Q1: What are AVAV’s main businesses?

AeroVironment is a defense technology company whose businesses cover Autonomous Systems (drones, loitering munitions, ground robots) and two major segments: Space, Cyber, and Directed Energy. Its core products include the Switchblade series of loitering munitions, the Puma and Raven reconnaissance drones, and the LOCUST laser weapon system.

Q2: How has AVAV performed in its most recent earnings?

In fiscal 2026 Q4, revenue was $641.6 million, up 133% year over year; full-year revenue was $1.977 billion, up 141% year over year. Non-GAAP adjusted earnings per share were $1.84, which was about 25% above analysts’ expectations.

Q3: How is AVAV’s order situation?

Full-year fiscal 2026 bookings reached $2.7 billion, with a book-to-bill ratio of 1.4. As of the end of the reporting period, funded backlog was $1.2 billion, up 65% year over year.

Q4: Why is AVAV’s earnings guidance below expectations?

The company expects fiscal 2027 revenue of $2.13 billion to $2.23 billion, but its earnings guidance is below market expectations. The main reason is that capital expenditures will rise sharply from 5% of revenue to 12% to 14%, to expand capacity.

Q5: What are AVAV’s main risks?

The main risks include: financial restatements and lawsuits related to the cancellation of the SCAR contract, capacity expansion execution risk, and a market environment with significant valuation divergence; also, the company’s revenue is highly concentrated among customers including the U.S. Department of Defense.

Q6: What is the general view of institutions on AVAV?

Institutional views are generally optimistic, but there are large differences in target prices. Wedbush gives an “Outperform” rating and a $250 target price; Stifel maintains a “Buy” rating but lowers its target price to $220; and the institutional consensus target-price median compiled by Barchart is about $295.